YTHDC2 plays a role in the different methylation levels observed in uterine corpus endometrioid carcinoma, adrenocortical carcinoma (ACC), and endocervical adenocarcinoma (CESC), leading to different prognoses and levels of immune cell infiltration [73]. The gene discussed is YTHDC2; the disease is adrenal cortex carcinoma.